Lojabark

Cinchona officinalis, commonly known as the cinchona tree or quinine bark, originates from South America and has a long-standing tradition in indigenous medicine. It is traditionally used for treating malaria due to its quinine content, which was historically recognized by the Quechua people before being adopted into Western medicine. Scientific evidence suggests that derivatives of quinine-chalcone hybrids exhibit potent cytotoxic and antiproliferative effects against EBC-1 cells, while leaf extracts show some improvement in antibiotic activity against multidrug-resistant Pseudomonas aeruginosa; however, these findings are preliminary and require further validation for clinical use. In vitro assays indicate that homeopathic Cinchona officinalis (CO)-MT may inhibit SARS-CoV-2 infection by 89%, comparable to remdesivir, though more research is needed to confirm these results. No significant safety concerns or drug interactions have been recorded for Cinchona officinalis; however, further studies are necessary to fully understand its potential benefits and risks.

Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.